Meta Information
ID:gait-and-balance-accelerometer
Name:Gait and Balance Accelerometer
Schema Version:1.5
Alternate Names
- Wearable Gait Sensor
- Inertial Measurement Unit (IMU) for Balance
Active Compound
null
Intervention Type
device
Delivery
Route:
none
Scope:
- local
Regulatory Status
- us:consumer_electronics
- us:medical_device_class_ii
Indication
Focus:
- healthspan
- disease_treatment
Description:
Quantifies gait speed, stride variability, and balance to assess fall risk, functional aging, and progression of neurological or musculoskeletal conditions.
Typical Protocol
- Continuous monitoring via a wearable device (e.g., smartwatch, hip-worn sensor).
- Periodic assessments (e.g., weekly timed up-and-go test) to track changes over time.
- Data is used to guide targeted exercises for balance and strength improvement.
Expected Cost Mean
Low Cost:
100
High Cost:
2500
Cost Type:
equipment
Description:
One-time cost for consumer wearables or specialized clinical-grade sensor systems. Clinical devices may be covered by insurance for specific diagnoses.
Summary
Gait and balance accelerometers are wearable sensors that provide objective data on movement patterns, such as gait speed, symmetry, and postural sway. These metrics are powerful predictors of frailty, fall risk, and all-cause mortality, making them crucial biomarkers for functional healthspan. By quantifying decline or improvement, these devices enable targeted interventions (e.g., specific exercises) to maintain mobility and independence.
Purpose
Quantifies functional aging and fall risk via movement data.
Card Summary
A wearable sensor that measures gait and balance, key predictors of frailty and mortality, to guide targeted exercise interventions.
Drug Class
null
Drugs In Class
Empty Array
Impact
Score:
6.5
Justification:
Provides critical, actionable data on a primary driver of functional decline and mortality.
Evidence
Grade:
A
Score:
9.5
Justification:
Vast body of observational data and meta-analyses link gait metrics to mortality.
Safety
Score:
0.5
Justification:
Passive, non-invasive monitoring device with negligible direct physical risk.
Flags
- Data interpretation may require clinical expertise for accurate assessment.
- Consumer-grade devices may have lower accuracy than clinical-grade systems.
- Over-reliance on data can lead to anxiety or obsessive tracking.
Verdict
A high-value tool for quantifying functional aging and guiding targeted exercise.
Created
2026-05-06T17:23:39.245811Z
Ai Model
Gemini 2.5 Pro (High)